Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation

References

• Bergquist A, Glaumann H, Persson B, et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology. 1998;27:311–316.
   PubMed Web of Science ®Google Scholar
• Walker SL, McCormick PA. Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an ‘evidence based radiology’ review. Abdominal Imag. 2008;33:14–17.
   PubMedGoogle Scholar
• Gores G. Cholangiocarcinoma: current concepts and insights. Hepatology. 2003;37:961–969.
   PubMed Web of Science ®Google Scholar
• Malhi H, Gores G. Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther. 2006;23:1287–1296.
   PubMed Web of Science ®Google Scholar
• Blechacz B, Gores G. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48:308–321.
   PubMed Web of Science ®Google Scholar
• Ghali P, Marotta P, Yoshida E, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl. 2005;11:1412–1416.
   PubMed Web of Science ®Google Scholar
• Boyd S, Tenca A, Jokelainen K, et al. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia. Endoscopy. 2016;48:432–439.
   PubMed Web of Science ®Google Scholar
• Aabakken L, Karlsen TH, Albert J, et al. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy. 2017;49:588–608.
   PubMed Web of Science ®Google Scholar
• Baron T, Harewood G, Rumalla A, et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol. 2004;2:214–219.
   PubMed Web of Science ®Google Scholar
• Weismüller T, Wedemeyer J, Kubicka S, et al. The challenges in primary sclerosing cholangitis – aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol. 2008;48:S38–S57.
   PubMed Web of Science ®Google Scholar
• Trikudanathan G, Navaneethan U, Njei B, et al. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc. 2014;79:783–789.
   PubMed Web of Science ®Google Scholar
• Arnelo U, von Seth E, Bergquist A. Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis. Endoscopy. 2015;47:696–702.
   PubMed Web of Science ®Google Scholar
• MacCarty RL, LaRusso NF, Wiesner RH, et al. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology. 1983;149:39–44.
   PubMed Web of Science ®Google Scholar
• LaRusso N, Shneider B, Black D, et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology. 2006;44:746–764.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–267.
   PubMed Web of Science ®Google Scholar
• Renshaw AA, Madge R, Jiroutek M, et al. Bile duct brushing cytology: statistical analysis of proposed diagnostic criteria. Am J Clin Pathol. 1998;110:635–640.
   PubMed Web of Science ®Google Scholar
• Cohen M, Wittchow R, Johlin F, et al. Brush cytology of the extrahepatic biliary tract: comparison of cytologic features of adenocarcinoma and benign biliary strictures. Mod Pathol. 1995;8:498–502.
   PubMed Web of Science ®Google Scholar
• Fleming F, Boberg KM, Glaumann H, et al. Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol. 2001;34:360–365.
   PubMed Web of Science ®Google Scholar
• Holzinger F, Z’graggen K, Büchler M. Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma. Ann Oncol. 1999;10 (Suppl 4):122–126.
   PubMed Web of Science ®Google Scholar
• Kocjan G, Smith AN. Bile duct brushings cytology: potential pitfalls in diagnosis. Diagn Cytopathol. 1997;16:358–363.
   PubMed Web of Science ®Google Scholar
• Fritcher E, Kipp B, Voss J, et al. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma. Am J Gastroenterol. 2011;106:2023–2028.
   PubMed Web of Science ®Google Scholar
• Layfield L, Cramer H. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases. Diagn Cytopathol. 2005;32:119–124.
   PubMed Web of Science ®Google Scholar
• Lal A, Okonkwo A, Schindler S, et al. Role of biliary brush cytology in primary sclerosing cholangitis. Acta Cytol. 2004;48:9–12.
   PubMed Web of Science ®Google Scholar
• Lee JG, Leung JW, Baillie J, et al. Benign, dysplastic, or malignant-making sense of endoscopic bile duct brush cytology: results in 149 consecutive patients. Am J Gastroenterol. 1995;90:722–726.
   PubMed Web of Science ®Google Scholar
• Lindberg B, Arnelo U, Bergquist A, et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy. 2002;34:909–916.
   PubMed Web of Science ®Google Scholar
• Siqueira E, Schoen R, Silverman W, et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc. 2002;56:40–47.
   PubMed Web of Science ®Google Scholar
• Bangarulingam S, Bjornsson E, Enders F, et al. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology. 2010;51:174–180.
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Njei B, Venkatesh P, et al. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc. 2014;79:943–950.e3.
   PubMed Web of Science ®Google Scholar
• Andersen IM, Fosby B, Boberg KM, et al. Indications and outcomes in liver transplantation in patients with primary sclerosing cholangitis in Norway. Transplant Direct. 2015;1:e39.
   PubMed Web of Science ®Google Scholar
• Heimbach J, Gores G, Haddock M, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis. 2004;24:201–207.
   PubMed Web of Science ®Google Scholar
• Wiesner R. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Best Pract Res Clin Gastroenterol. 2001;15:667–680.
   PubMed Web of Science ®Google Scholar
• Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. 2000;69:1633–1637.
   PubMed Web of Science ®Google Scholar